Innoviva, Inc. - Mar 12, 2025 Form SCHEDULE 13D/A Schedule Report for Armata Pharmaceuticals, Inc. (ARMP)

Filing Manager
Innoviva, Inc.
Reporting Manager
Innoviva, Inc.
Security
Armata Pharmaceuticals, Inc. Common Stock, $0.01 par value
Symbol
ARMP
Shares outstanding
75.3M shares
Disclosed Ownership
64.2M shares
Ownership
85.2%
Form type
SCHEDULE 13D/A
Date filed
3/12/2025, 05:49 PM
Date of event
Mar 12, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Innoviva, Inc. 85.2% 64.2M 17.4M 46.8M /s/ Pavel Raifeld Pavel Raifeld, Chief Executive Officer 0001080014
Innoviva Strategic Opportunities LLC 62.1% 46.8M 0 46.8M /s/ Pavel Raifeld Pavel Raifeld, Chief Executive Officer